BIMI International Medical Inc. (BIMI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK, NY NEW YORK |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,932 | 1,730 | 2,337 | 1,047 | 5,034 | 1,606 | |||
| Cash and cash equivalents | 1,932 | 1,730 | 2,337 | 1,047 | 5,034 | 1,606 | |||
| Receivables | 6,380 | 3,915 | 3,208 | 7,662 | 6,247 | 8,293 | |||
| Inventory, net of allowances, customer advances and progress billings | 7,183 | 8,465 | 7,654 | 1,230 | 3,028 | 2,170 | |||
| Inventory | 7,183 | 8,465 | 7,654 | 1,230 | 3,028 | 2,170 | |||
| Prepaid expense | 7,017 | 7,317 | 6,646 | 216 | 58 | 62 | |||
| Deferred costs | (70,144) | 794 | 794 | 1,011 | |||||
| Intangible current assets | 16 | ||||||||
| Business combination, contingent consideration, asset | 1,498 | ||||||||
| Other undisclosed current assets | 1,985 | 3,550 | 73,534 | 6,419 | 9,016 | 8,913 | |||
| Total current assets: | 25,995 | 24,978 | 23,236 | 17,384 | 24,177 | 22,054 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 2,836 | 3,029 | 2,942 | 3,977 | 4,336 | 4,711 | |||
| Property, plant and equipment | 1,690 | 1,792 | 1,703 | 2,884 | 3,112 | 3,344 | |||
| Long-term investments and receivables | 1,800 | ||||||||
| Long-term investments | 1,800 | ||||||||
| Intangible assets, net (including goodwill) | 2,515 | 2,578 | 2,082 | 8,392 | 8,393 | 8,394 | |||
| Goodwill | 2,066 | 2,066 | 2,066 | 8,376 | 8,376 | 8,376 | |||
| Intangible assets, net (excluding goodwill) | 449 | 512 | 16 | 16 | 17 | 18 | |||
| Disposal group, including discontinued operation, noncurrent assets | 3,439 | ||||||||
| Deferred income tax assets | 183 | 193 | 190 | 186 | 197 | 208 | |||
| Other undisclosed noncurrent assets | 3,705 | 3,761 | 180 | ||||||
| Total noncurrent assets: | 10,663 | 11,296 | 12,479 | 15,619 | 16,039 | 16,658 | |||
| TOTAL ASSETS: | 36,658 | 36,274 | 35,714 | 33,003 | 40,217 | 38,712 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 11,907 | 12,326 | 12,993 | 9,948 | 6,897 | 8,015 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 390 | 524 | 693 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 686 | ✕ | ✕ | ||
| Accounts payable | 9,605 | 10,093 | 10,786 | 4,232 | 5,850 | 6,629 | |||
| Accrued liabilities | 2,302 | 2,232 | 2,207 | 4,639 | 524 | 693 | |||
| Debt | 1,236 | 993 | 924 | 1,566 | 2,026 | 1,978 | |||
| Other liabilities | 589 | 614 | 630 | 1,122 | 1,069 | 146 | |||
| Due to related parties | ✕ | ✕ | ✕ | 4,600 | 476 | 503 | 532 | ||
| Other undisclosed current liabilities | 5,658 | 8,677 | 6,215 | 5,788 | 11,014 | 10,023 | |||
| Total current liabilities: | 19,391 | 22,609 | 25,362 | 18,899 | 21,509 | 20,694 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 126 | 160 | 315 | 3,894 | 4,312 | 4,624 | |||
| Long-term debt, excluding current maturities | 126 | 160 | 315 | 475 | 472 | 529 | |||
| Liabilities, other than long-term debt | 2,681 | 2,587 | 2,575 | ||||||
| Accounts payable and accrued liabilities | 266 | ||||||||
| Operating lease, liability | 2,415 | 2,587 | 2,575 | 3,419 | 3,840 | 4,095 | |||
| Other undisclosed noncurrent liabilities | 1,948 | 2,298 | 2,245 | (3,419) | (3,840) | (4,095) | |||
| Total noncurrent liabilities: | 4,755 | 5,046 | 5,135 | 3,894 | 4,312 | 4,624 | |||
| Total liabilities: | 24,146 | 27,654 | 30,497 | 22,793 | 25,821 | 25,318 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 10,887 | 7,605 | 4,048 | 9,798 | 14,157 | 13,252 | |||
| Common stock | 6 | 4 | 4 | 38 | 23 | 10 | |||
| Additional paid in capital | 77,417 | 77,424 | 71,899 | 65,760 | 65,834 | 60,566 | |||
| Accumulated other comprehensive income (loss) | (502) | (1,060) | 25 | 234 | 634 | 1,052 | |||
| Accumulated deficit | (68,299) | (71,027) | (70,144) | (56,234) | (52,333) | ||||
| Other undisclosed equity, attributable to parent | 2,264 | 2,264 | 2,264 | (48,376) | |||||
| Equity, attributable to noncontrolling interest | 1,626 | 1,014 | 1,170 | 412 | 238 | 142 | |||
| Total equity: | 12,512 | 8,619 | 5,217 | 10,210 | 14,396 | 13,394 | |||
| TOTAL LIABILITIES AND EQUITY: | 36,658 | 36,274 | 35,714 | 33,003 | 40,217 | 38,712 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 5,558 | 3,198 | (5,432) | 7,315 | 4,927 | 5,020 | ||
| Other operating income | 884 | 2,740 | ||||||
| Cost of revenue | (2,674) | (1,507) | 3,113 | (5,730) | (3,702) | (3,561) | ||
| Gross profit: | 2,884 | 1,690 | (2,319) | 1,585 | 1,225 | 1,458 | ||
| Operating expenses | (1,585) | (1,109) | (5,092) | (4,677) | (3,504) | (4,015) | ||
| Operating income (loss): | 1,299 | 581 | (7,411) | (3,092) | (2,279) | (2,557) | ||
| Nonoperating income (expense) | (125) | (1,441) | (3,641) | (623) | (1,859) | (161) | ||
| Investment income, nonoperating | 0 | 0 | (3,261) | 0 | 0 | 0 | ||
| Other nonoperating income (expense) | (1,408) | (576) | (470) | (1,751) | (50) | |||
| Interest and debt expense | (35) | (35) | 146 | (97) | (112) | (108) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 1,140 | (896) | (10,905) | (3,812) | (4,250) | (2,826) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 35 | 35 | (146) | 97 | 112 | 108 | ||
| Income (loss) from continuing operations before income taxes: | 1,174 | (861) | (11,051) | (3,715) | (4,138) | (2,718) | ||
| Income tax expense (benefit) | 24 | 1 | (8) | (23) | ||||
| Income (loss) from continuing operations: | 1,174 | (861) | (11,027) | (3,714) | (4,146) | (2,740) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (3,714) | (4,146) | (2,740) | |
| Loss from discontinued operations | (120) | |||||||
| Other undisclosed net loss | (0) | (23) | (690) | |||||
| Net income (loss): | 1,054 | (884) | (11,717) | (3,714) | (4,146) | (2,740) | ||
| Net income (loss) attributable to noncontrolling interest | (0) | (0) | (79) | 1 | 1 | 1 | ||
| Net income (loss) attributable to parent: | 1,054 | (884) | (11,796) | (3,713) | (4,145) | (2,739) | ||
| Other undisclosed net income (loss) available to common stockholders, basic | 349 | (1) | ||||||
| Net income (loss) available to common stockholders, basic: | 1,054 | (884) | (11,447) | (3,713) | (4,145) | (2,740) | ||
| Other undisclosed net income available to common stockholders, diluted | 0 | 75 | ||||||
| Net income (loss) available to common stockholders, diluted: | 1,054 | (884) | (11,372) | (3,713) | (4,145) | (2,740) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,054 | (884) | (11,717) | (3,714) | (4,146) | (2,740) | ||
| Other comprehensive income (loss) | 106 | (2,844) | ||||||
| Other undisclosed comprehensive income (loss) | (860) | 1,759 | (210) | (400) | ||||
| Comprehensive income (loss): | 301 | (1,968) | (11,927) | (4,114) | (4,146) | (2,740) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 568 | 897 | 30 | 488 | 510 | 25 | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (418) | (550) | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | 869 | (1,071) | (11,897) | (3,626) | (4,054) | (3,266) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.